Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Engineering the Interface between Inorganic Nanoparticles and Biological Systems through Ligand Design.
In situ activation of therapeutics through bioorthogonal catalysis.
The Why and How of Ultrasmall Nanoparticles.
See All 3 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The Why and How of Ultrasmall Nanoparticles.
Epple M, Rotello VM, Dawson K. The Why and How of Ultrasmall Nanoparticles. Acc Chem Res. 2023 12 05; 56(23):3369-3378.
View in:
PubMed
subject areas
Nanoparticles
Nanostructures
authors with profiles
Vincent Rotello PhD